Arkema falls after outlook misses expectations

Arkema SA

27/02/2025 08:37

** Shares in Arkema AKE.PA fall around 6% after the French speciality chemicals group announced guidance below expectations

** Arkema aims for its EBITDA in 2025 to reach between 1.53 billion and 1.67 billion euros, with a first quarter slightly below last year

** That compares with 1.64 billion euros in company-compiled consensus, which J.P.Morgan notes is 2.6% below at midpoint

** "1Q adj EBITDA guide well below consensus and might also raise concerns on FY25 guide", JPM says

** Up to the previous session's close, shares were up 13.5%​ YTD

 (Reporting by Marianna Ciabach-Malinowska)

 ((Marianna.ciabach@thomsonreuters.com))